arrow
T

T. Huizinga

rheumatology
H指数:140
被引数:10.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Location and amount of joint involvement differentiates rheumatoid arthritis into different clinical subsets

关节受累的部位和程度将类风湿关节炎区分为不同的临床亚型。

2025-10-230
OAAI
Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report

belimumab与rituximab联合治疗重症难治性SLE的长期安全性与有效性:初步报告

2025-10-010
OAAI
Treatment outcomes stratified by interferon profile and autoantibodies in rheumatoid arthritis

类风湿关节炎中按干扰素谱和自身抗体分层的治疗效果

2025-09-300
PRE
Semi-quantitatively scored apical extent of disease predicts change in total lung capacity in patients with systemic sclerosis and early interstitial lung disease.

半定量评分的疾病尖顶范围可预测系统性硬化症伴早期间质性肺疾病患者总肺容量的变化。

2025-04-010
OAAI
Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report

贝利木单抗联合利妥昔单抗治疗重症和难治性SLE的长期安全性和有效性: 初步报告

2025-02-120
OAAI